Company Profiles

driven by the PitchBook Platform

VentiRx Pharmaceuticals

Description

Developer of therapeutics for the treatment of cancer, respiratory, allergy and autoimmune inflammatory diseases. The company develops and commercializes toll like receptor 8 (TLR8) immunotherapies.

2006

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$15M

Latest Deal Amount

$104M

Total Amount Raised

Description

Developer of therapeutics for the treatment of cancer, respiratory, allergy and autoimmune inflammatory diseases. The company develops and commercializes toll like receptor 8 (TLR8) immunotherapies.

Website:

www.ventirx.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Primary Office

1191 Second Avenue Suite 1105 Seattle, WA 98101United States +1 (206) 689-2259
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore VentiRx Pharmaceuticals's full profile, request a free trial.

VentiRx Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

VentiRx Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

VentiRx Pharmaceuticals Investors (5)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
ARCH Venture PartnersVenture CapitalMinority000 0000000 0000
CelgeneCorporationMinority000 0000000 0000
Domain AssociatesVenture CapitalMinority000 0000000 0000
Frazier HealthcareGrowth/ExpansionMinority000 0000000 0000
MedImmune VenturesCorporate Venture CapitalMinority000 0000000 0000
ARCH Venture Partners Venture Capital
Celgene Corporation
Domain Associates Venture Capital
Frazier Healthcare Growth/Expansion
MedImmune Ventures Corporate Venture Capital

VentiRx Pharmaceuticals Executive Team (9)

NameTitleBoard
Seat
Contact
Info
Robert Hershberg Ph.DPresident, Chief Executive Officer, Board Member & Founder
Kathleen FanningChief Operating Officer
Mona NewkirkDirector, Clinical Operations
Timothy FitzpatrickHead, Pharmaceutical Manufacturing
Kristi ManjarrezVice President, Clinical Affairs
Robert Hershberg Ph.D President, Chief Executive Officer, Board Member & Founder
Kathleen Fanning Chief Operating Officer
Mona Newkirk Director, Clinical Operations
Timothy Fitzpatrick Head, Pharmaceutical Manufacturing
Kristi Manjarrez Vice President, Clinical Affairs

VentiRx Pharmaceuticals Board Members (7)

NameRepresentingRoleSinceContact
Info
Atul SaranSelfBoard Member000 0000
Elliott GrossbardSelfBoard Member000 0000
Kent SnyderSelfBoard Member000 0000
Nicole VitulloDomain AssociatesPartner000 0000
Patrick HeronFrazier HealthcareManaging General Partner, Life Sciences000 0000
Atul Saran Board Member Self
Elliott Grossbard Board Member Self
Kent Snyder Board Member Self
Nicole Vitullo Partner Domain Associates
Patrick Heron Managing General Partner, Life Sciences Frazier Healthcare
Request full access to PitchBook